Effective Care Management of Depressed Diabetes Patients (The Positive Steps Study)
NCT ID: NCT01106885
Last Updated: 2015-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
339 participants
INTERVENTIONAL
2005-05-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Stepped Care Approach to Manage Depression in Diabetes
NCT01812291
Web-Based Collaborative Care for Patients With Diabetes and Depression
NCT01985711
mHealth Skill Enhancement Plus Phone CBT for Type 2 Diabetes Distress Medication Nonadherence: Pilot Study
NCT02081586
Cognitive Behavioral Intervention in Diabetes Self-Management
NCT01182701
Program ACTIVE II: Behavioral Depression Treatment for Type 2 Diabetes
NCT03371940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: Surveys: Patients will complete clinic-based surveys at baseline and 12-months to measure their health status, self-care, provider-patient communication, and resource use. At 4 months, they will complete a mailed questionnaire to capture short-term changes in depressive symptoms, walking, patient-provider communication, medication adherence, and quality-of-life. Physiologic Measures: At baseline and 12-months, patients' A1c and cholesterol will be measured via a fingerstick blood test. We also will measure blood pressure, height, and weight. With patients' 4-month mailed surveys, they will complete fingerstick A1c tests and return the results via mail. The blood tests are identical to those diabetes patients use to self-monitor their blood glucose. Pedometers: We will measure distance walked at baseline, 4 months, and 12 months using a pedometer. Patients will record their walk distances for one week and return the results via mail. Electronic data: Utilization and billing databases will be used to identify health service utilization (ER visits, outpatient care, hospitalizations) occurring during patients' participation and the prior 12 months. Physician feedback. At patients' 12-month assessment, the physician will complete a brief survey about the patient's communication style. All patients will provide written consent administered prior to their face-to-face screening and baseline interviews. Physician 12-month surveys about patients' communication style will be anonymous.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enhanced Usual Care
Adult patients with diabetes and depression.
* Report screening results
* Notify PCP of screening results (optional per patient)
* PCP referrals
* Educational materials regarding diabetes, physical activity, and depression
No interventions assigned to this group
Staged Care Management
Adult patients with diabetes and depression
Medication Care Management (MCM)
* Basic physical activity counseling
* Notify PCP and facilitate initiation of antidepressants
* Medication monitoring calls at 1, 2, 4, 6, 8, 10, and 12 weeks\*
* 1/mo monitoring in continuation phase (mos. 4-12)\*
* Report \& recommendations to PCP after each patient call
* Note: \*average of 10 minutes of telephone time each (series is repeated if second antidepressant trial is needed)
Cognitive-Behavioral Therapy (CBT)
* Notify PCP
* CBT Manual
* Weekly CBT focused counseling for 12 weeks\*\*
* Monthly CBT in months 4-12\*\*
* Behavioral physical activity counseling
* Report \& recommendations to PCP after each patient call
* Note: \*\*average of 50 minutes of telephone time each
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medication Care Management (MCM)
* Basic physical activity counseling
* Notify PCP and facilitate initiation of antidepressants
* Medication monitoring calls at 1, 2, 4, 6, 8, 10, and 12 weeks\*
* 1/mo monitoring in continuation phase (mos. 4-12)\*
* Report \& recommendations to PCP after each patient call
* Note: \*average of 10 minutes of telephone time each (series is repeated if second antidepressant trial is needed)
Cognitive-Behavioral Therapy (CBT)
* Notify PCP
* CBT Manual
* Weekly CBT focused counseling for 12 weeks\*\*
* Monthly CBT in months 4-12\*\*
* Behavioral physical activity counseling
* Report \& recommendations to PCP after each patient call
* Note: \*\*average of 50 minutes of telephone time each
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of depression
* Using hypoglycemic medications
* At least 1 outpatient visit in last 12 months
* At least 21 years old
Exclusion Criteria
* End stage renal disease
* Lung cancer
* Dementia
* Bipolar
* Schizophrenia
* Can't speak English
* Memory problems
* Alcohol problems
* Illegal drug use
* Minimal depressive symptoms
* Blood pressure 180/110 or higher
* Problems with loss of consciousness
* Can't walk 10 minutes on level surface
* Not planning to get their care at study site
* PCP not affiliated with study site
* Are not on a stable regimen (change in depression Rx in last 28-30 days)
* Type 1 diabetic if diagnosed before age 15
21 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
Genesys Health System
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John Piette
VA Senior Research Career Scientist and Professor of Internal Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John D Piette, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Ann Arbor Healthcare System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Ann Arbor Healthcare System
Ann Arbor, Michigan, United States
University of Michigan Health System
Ann Arbor, Michigan, United States
Genesys Regional Medical Center
Grand Blanc, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Piette JD, Valenstein M, Himle J, Duffy S, Torres T, Vogel M, Richardson C. Clinical complexity and the effectiveness of an intervention for depressed diabetes patients. Chronic Illn. 2011 Dec;7(4):267-78. doi: 10.1177/1742395311409259. Epub 2011 Aug 12.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.